LncRNA CASC9 was firstly reported in esophageal squamous cell carcinoma as an oncogene in 2015, and was subsequently confirmed to be associated with tumorigenesis and progression of malignant tumors including gastric cancer, hepatocellular carcinoma and breast cancer (12–14). This evidence concerns the gene CASC9 and cancer.